glycopyrrolate has been researched along with Cardiac Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghelfi, E; González-Flecha, B; Lawrence, J; Rhoden, CR; Wellenius, GA | 1 |
| Mostafa, SM; Vucevic, M | 1 |
| Berguson, P; Preiss, D | 1 |
1 review(s) available for glycopyrrolate and Cardiac Diseases
| Article | Year |
|---|---|
Glycopyrronium for inhalation. COPD: another antimuscarinic with cardiac adverse effects that require monitoring.
Topics: Administration, Inhalation; Clinical Trials as Topic; Drug Interactions; Electrocardiography; Glycopyrrolate; Heart Diseases; Humans; Muscarinic Antagonists; Pulmonary Disease, Chronic Obstructive | 2014 |
1 trial(s) available for glycopyrrolate and Cardiac Diseases
| Article | Year |
|---|---|
Comparison of atropine and glycopyrronium in patients with pre-existing cardiac disease.
Topics: Aged; Atropine; Blood Pressure; Coronary Disease; Double-Blind Method; Electrocardiography; Female; Glycopyrrolate; Heart Diseases; Heart Rate; Humans; Intubation, Intratracheal; Male; Myocardial Infarction; Pyrrolidines; Random Allocation; Surgical Procedures, Operative; Time Factors | 1984 |
2 other study(ies) available for glycopyrrolate and Cardiac Diseases
| Article | Year |
|---|---|
PM-induced cardiac oxidative stress and dysfunction are mediated by autonomic stimulation.
Topics: Acetylcholine; Acetylcysteine; Air Pollutants; Animals; Autonomic Agents; Autonomic Nervous System; Glycopyrrolate; Heart Diseases; Heart Rate; Inhalation Exposure; Isoproterenol; Male; Muscarine; Oxidative Stress; Particle Size; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species | 2005 |
Dose-response studies on glycopyrrolate and atropine in conscious cardiac patients.
Topics: Atropine; Dose-Response Relationship, Drug; Glycopyrrolate; Heart Diseases; Heart Rate; Humans; Premedication; Pyrrolidines | 1983 |